Concepedia

Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial

Betty Mwesigwa, Katherine V. Houser, Amelia R. Hofstetter, Ana M. Ortega‐Villa, Prossy Naluyima, Francis Kiweewa, Immaculate Nakabuye, Galina V. Yamshchikov, Charla Andrews, Mark O’Callahan,

The Lancet Infectious Diseases · 2023 · 24 citations · 16 references

DOIFull text

Open access

Concepts

References

16

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

Heinz Feldmann, Ute Ströher, Joan B. Geisbert et al. · Nature Medicine · 2005 · 690 citations

, , +16

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

Daphne A. Stanley, Anna N. Honko, Clement Asiedu et al. · Nature Medicine · 2014 · 352 citations

, , +16

Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species

Stefano Colloca, Eleanor Barnes, Antonella Folgori et al. · Science Translational Medicine · 2012 · 303 citations

, , +16

Chimpanzee Adenovirus Vector Ebola Vaccine

Julie E. Ledgerwood, Adam DeZure, Daphne A. Stanley et al. · New England Journal of Medicine · 2014 · 283 citations · Full text

, , +16

Analysis of Human Peripheral Blood Samples from Fatal and Nonfatal Cases of Ebola (Sudan) Hemorrhagic Fever: Cellular Responses, Virus Load, and Nitric Oxide Levels

Anthony Sanchez, Matthew Lukwiya, Daniel G. Bausch et al. · Journal of Virology · 2004 · 276 citations · Full text

, , +16